Last updated on April 2019

A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy


Brief description of study

This is a multicenter, double blind, placebo controlled, multiple dose study to examine the safety and efficacy of MNK-1411 in male subjects 4 to 8 years of age (inclusive) with Duchenne Muscular Dystrophy (DMD).

Clinical Study Identifier: NCT03400852

Find a site near you

Start Over